These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 26499042)

  • 1. Kinetics of the establishment of HIV-1 viral interference and comprehensive analysis of the contribution of viral genes.
    Remion A; Delord M; Hance AJ; Saragosti S; Mammano F
    Virology; 2016 Jan; 487():59-67. PubMed ID: 26499042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption.
    de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA
    AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cells.
    Kim JH; Mosca JD; Vahey MT; McLinden RJ; Burke DS; Redfield RR
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):875-82. PubMed ID: 7504936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction between HIV-1 and GB virus type-C during coinfection status].
    Arroyave JC; Pujol FH; Navas MC; Cortés-Mancera FM
    Rev Chilena Infectol; 2013 Feb; 30(1):31-41. PubMed ID: 23450407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal.
    Zhang J; Liu Y; Henao J; Rugeles MT; Li J; Chen T; He JJ
    Gene; 2005 Dec; 363():67-76. PubMed ID: 16236470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
    Wildum S; Schindler M; Münch J; Kirchhoff F
    J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo down regulation of HIV replication after hepatitis C superinfection.
    Flichman D; Cello J; Castaño G; Campos R; Sookoian S
    Medicina (B Aires); 1999; 59(4):364-6. PubMed ID: 10752201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1.
    Little SJ; Riggs NL; Chowers MY; Fitch NJ; Richman DD; Spina CA; Guatelli JC
    Virology; 1994 Dec; 205(2):578-82. PubMed ID: 7975260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of various HIV-1 mutants to inhibit the replication of wild-type virus.
    Inubushi R; Shimano R; Oshima Y; Adachi A
    Biochem Biophys Res Commun; 1998 Jun; 247(2):349-52. PubMed ID: 9642129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of viral RNA synthesis following cell-to-cell transmission of human immunodeficiency virus type 1.
    Davis AJ; Li P; Burrell CJ
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1897-906. PubMed ID: 9266985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous superinfection of both producer and nonproducer HIV-infected cells is blocked at a late retrotranscription step.
    Taddeo B; Federico M; Titti F; Rossi GB; Verani P
    Virology; 1993 Jun; 194(2):441-52. PubMed ID: 8503167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synonymous mutations in stem-loop III of Rev responsive elements enhance HIV-1 replication impaired by primary mutations for resistance to enfuvirtide.
    Ueno M; Kodama EN; Shimura K; Sakurai Y; Kajiwara K; Sakagami Y; Oishi S; Fujii N; Matsuoka M
    Antiviral Res; 2009 Apr; 82(1):67-72. PubMed ID: 19428597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
    Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
    J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
    Liem SE; Ramezani A; Li X; Joshi S
    Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activity.
    Boons E; Li G; Vanstreels E; Vercruysse T; Pannecouque C; Vandamme AM; Daelemans D
    Antiviral Res; 2014 Dec; 112():91-102. PubMed ID: 25453342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity.
    Asin SN; Wildt-Perinic D; Mason SI; Howell AL; Wira CR; Fanger MW
    J Infect Dis; 2003 May; 187(10):1522-33. PubMed ID: 12721932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression.
    Woolaway K; Asai K; Emili A; Cochrane A
    Retrovirology; 2007 Apr; 4():28. PubMed ID: 17451601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
    Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
    Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.